LGD-4033 (Ligandrol)

Description

What is Ligandrol (LGD-4033)? 

LGD-4033, commonly known as Ligandrol, is a selective androgen receptor modulator (SARM) developed as a non-steroidal compound for research into androgen receptor biology, muscle physiology, and metabolic regulation. Unlike traditional anabolic-androgenic steroids, SARMs are designed to selectively interact with androgen receptors in specific tissues, with the goal of understanding tissue-selective androgen signaling.

LGD-4033 has been studied for its ability to bind and activate androgen receptors, which are nuclear hormone receptors involved in regulating gene expression related to muscle protein synthesis, skeletal muscle maintenance, bone biology, and other androgen-responsive processes. The degree of tissue selectivity and the long-term physiological consequences of androgen receptor modulation remain areas of ongoing investigation. Research has examined LGD-4033’s effects on lean body mass, muscle-related biomarkers, and endocrine parameters.

• Compound / Peptide name: LGD-4033 (Ligandrol)
• Classification: Selective Androgen Receptor Modulator (SARM); non-steroidal androgen receptor ligand
• Sequence (if applicable): Not applicable
• Molecular Formula: C14H12F6N2O
• Molecular Weight: Not consistently reported in provided information
• Form: Tablet
• Strength: 10 mg per tablet
• Purity: 99%
• Appearance: Tablet form; physical characteristics depend on formulation
• Storage: Store according to supplier specifications
• Solubility: Research-dependent
• Regulatory Status: Investigational compound; not approved for human consumption or therapeutic use

What Is It Used For and Its Purpose 

LGD-4033 is primarily investigated as a research tool for studying androgen receptor activation and its effects on skeletal muscle, bone metabolism, and metabolic physiology. Researchers use SARMs such as LGD-4033 to explore whether selective receptor modulation can influence anabolic signaling pathways while providing insights into tissue-specific androgen biology.

Experimental research has examined LGD-4033 in relation to muscle protein synthesis, lean mass regulation, and endocrine responses. Studies have also investigated its effects on biomarkers associated with androgen receptor activity and body composition changes. The compound is of interest because androgen receptor signaling plays an important role in maintaining muscle tissue, regulating bone physiology, and influencing metabolic processes. Understanding selective receptor activation may contribute to broader knowledge of hormone receptor pharmacology.

Research Application

• Endocrinology and androgen receptor signaling
• Skeletal muscle biology
• Body composition research
• Bone metabolism studies
• Molecular pharmacology
• Hormone receptor research
• Metabolic physiology

Potential Scientific Benefits 

Research on LGD-4033 has focused on its interaction with androgen receptors and its potential influence on anabolic signaling pathways. In preclinical studies and investigations, LGD-4033 has demonstrated biological activity consistent with androgen receptor modulation. A randomized clinical study published through the National Library of Medicine evaluated short-term LGD-4033 administration in healthy men and reported measurable changes in lean body mass and androgen-related biomarkers.

In laboratory models, androgen receptor activation has been associated with regulation of muscle protein synthesis, muscle cell signaling, and bone-related pathways. LGD-4033’s selective receptor activity has been investigated as a mechanism for understanding whether anabolic signaling can be influenced in a tissue-dependent manner.

Observed biological activities in research:

• Binding and activation of androgen receptors
• Investigation of anabolic signaling pathways
• Changes in lean body mass parameters in limited clinical research
• Modulation of androgen-responsive gene expression
• Study of skeletal muscle and bone-related pathways
• Examination of endocrine responses associated with androgen receptor activity

Molecular mechanisms reported:

• Selective androgen receptor agonism
• Regulation of androgen-responsive transcription
• Influence on pathways associated with muscle maintenance and growth

Physiological pathways involved:

• Androgen receptor signaling
• Skeletal muscle protein metabolism
• Bone remodeling pathways
• Hormonal regulation mechanisms

Current evidence remains limited, and further well-controlled clinical studies are required to establish long-term efficacy and safety in humans.

Research Data Sheet 

• Compound / Peptide name: LGD-4033 (Ligandrol)
• Sequence (if applicable): Not applicable
• Classification: Selective Androgen Receptor Modulator (SARM)
• Molecular Formula: C14H12F6N2O
• Molecular Weight: Not available
• Form: Tablet
• Appearance: Tablet form
• Purity: 99%
• Solubility: Research-dependent
• Storage: Follow supplier-provided storage instructions
• Research Categories: Endocrinology, androgen receptor signaling, muscle biology, bone metabolism, molecular pharmacology

Safety Precautions 

LGD-4033 is supplied strictly for laboratory research purposes. Handling should be performed by qualified researchers using appropriate laboratory procedures and documentation practices. Potential effects on endocrine function, cardiovascular physiology, liver parameters, and long-term health outcomes require further investigation.

• Research use only
• Not for human consumption
• Not intended to diagnose, treat, or prevent disease
• Use appropriate PPE including gloves, laboratory coat, and eye protection
• Follow aseptic handling procedures where applicable
• Maintain proper storage conditions
• Avoid unnecessary freeze–thaw cycles where applicable
• Maintain accurate labeling and documentation
• Dispose of materials according to laboratory waste regulations
• Limited human safety data available
• Potential unknown long-term biological effects

Conclusion 

LGD-4033 (Ligandrol) is an investigational selective androgen receptor modulator studied for its effects on androgen receptor signaling, skeletal muscle biology, and metabolic physiology. Its development has provided researchers with a tool for examining how selective activation of androgen pathways may influence different tissues.

Scientific studies have investigated LGD-4033 through preclinical models and limited human research, with findings related to androgen receptor activity, lean mass parameters, and endocrine responses. The compound continues to be relevant in pharmacological research focused on nuclear receptor biology, anabolic signaling mechanisms, and tissue-selective hormone modulation.